Name: | Description: | Size: | Format: | |
---|---|---|---|---|
168.22 KB | Adobe PDF |
Advisor(s)
Abstract(s)
Presymptomatic Testing (PST) for Huntington’s disease (HD) is available since 1986 and its impact on carriers and non-carriers is not yet fully clear. It is important to understand its psychological impact so that the PST protocols are best suited to the subjects at-risk. Preventing a negative psychological impact is the ultimate purpose of the genetic counselling process. This study addresses the long-term negative psychological impact assessment of PST for HD. The sample consisted of 29 subjects that were 50% at-risk for HD, and had performed the PST for at least three years ago. Participants answered the sociodemographic questionnaire and the Brief Symptom Inventory, the Zung Self-Rating Anxiety Scale, and the Beck Depression Inventory. Although most of the sample does not present clinically significant psychopathology values, 6 subjects present a Positive Symptoms Distress Index value which is equal to or greater than 1.7; 7 subjects present a value which is equal to or greater than 40 of anxiety; and 7 subjects present mild depression. Symptomatic carriers, who underwent the PST less time ago, present worse psychopathological symptoms, depression and anxiety. Subjects with this profile should have a more intense and personalized psychological and social support, aiming to prevent the risk of suicide and to improve the quality of their lives.
Description
http://sherpa.ac.uk/romeo/issn/2422-8419/
Keywords
Presymptomatic Testing (PST) Preditive genetic testing Huntington´s Disease (HD) Long-term Psychological Impact Late-onset disease
Citation
APA: Leite, Â. M. T., Dinis, M. A. P., Pinto, S. M. L. d. S., Pinto, A. M. B. C., Gomes, A. I. P., & e Sousa, H. F. P. (2017). Long-term negative Psychological Impact of Presymptomatic Testing for Huntington’s Disease. Journal of Health, Medicine and Nursing, 34, 1-9.
Publisher
International Peer Reviewed Journal and Book Publishing